Global AI-Enabled Imaging Modalities Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • AI-Enabled Imaging Modalities market report explains the definition, types, applications, major countries, and major players of the AI-Enabled Imaging Modalities market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Koninklijke Philips NV

    • General Electric Company

    • Fujifilm

    • United Health Imaging

    • Siemens Healthineers AG

    • Konica Minolta Inc

    • Nanox

    • Butterfly Network Inc

    • Agfa

    • Hologic

    • Canon Inc

    • Exo

    • Hyperfine

    By Type:

    • Computed Tomography (CT)

    • MRI

    • X-Ray

    • Ultrasound

    • Positron Emission Tomography (PET)

    • Other Modalities

    By End-User:

    • Cardiology

    • Oncology

    • Neurology

    • Pulmonology

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global AI-Enabled Imaging Modalities Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 AI-Enabled Imaging Modalities Outlook to 2028- Original Forecasts

    • 2.2 AI-Enabled Imaging Modalities Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term AI-Enabled Imaging Modalities Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global AI-Enabled Imaging Modalities Market- Recent Developments

    • 6.1 AI-Enabled Imaging Modalities Market News and Developments

    • 6.2 AI-Enabled Imaging Modalities Market Deals Landscape

    7 AI-Enabled Imaging Modalities Raw Materials and Cost Structure Analysis

    • 7.1 AI-Enabled Imaging Modalities Key Raw Materials

    • 7.2 AI-Enabled Imaging Modalities Price Trend of Key Raw Materials

    • 7.3 AI-Enabled Imaging Modalities Key Suppliers of Raw Materials

    • 7.4 AI-Enabled Imaging Modalities Market Concentration Rate of Raw Materials

    • 7.5 AI-Enabled Imaging Modalities Cost Structure Analysis

      • 7.5.1 AI-Enabled Imaging Modalities Raw Materials Analysis

      • 7.5.2 AI-Enabled Imaging Modalities Labor Cost Analysis

      • 7.5.3 AI-Enabled Imaging Modalities Manufacturing Expenses Analysis

    8 Global AI-Enabled Imaging Modalities Import and Export Analysis (Top 10 Countries)

    • 8.1 Global AI-Enabled Imaging Modalities Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global AI-Enabled Imaging Modalities Export by Region (Top 10 Countries) (2017-2028)

    9 Global AI-Enabled Imaging Modalities Market Outlook by Types and Applications to 2022

    • 9.1 Global AI-Enabled Imaging Modalities Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Computed Tomography (CT) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global MRI Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global X-Ray Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Ultrasound Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Positron Emission Tomography (PET) Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Modalities Consumption and Growth Rate (2017-2022)

    • 9.2 Global AI-Enabled Imaging Modalities Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Neurology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pulmonology Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise AI-Enabled Imaging Modalities Market Analysis and Outlook till 2022

    • 10.1 Global AI-Enabled Imaging Modalities Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.2.2 Canada AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.2.3 Mexico AI-Enabled Imaging Modalities Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.2 UK AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.3 Spain AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.4 Belgium AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.5 France AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.6 Italy AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.7 Denmark AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.8 Finland AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.9 Norway AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.10 Sweden AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.11 Poland AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.12 Russia AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.3.13 Turkey AI-Enabled Imaging Modalities Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.2 Japan AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.3 India AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.4 South Korea AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.5 Pakistan AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.6 Bangladesh AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.7 Indonesia AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.8 Thailand AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.9 Singapore AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.10 Malaysia AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.11 Philippines AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.4.12 Vietnam AI-Enabled Imaging Modalities Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.5.2 Colombia AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.5.3 Chile AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.5.4 Argentina AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.5.5 Venezuela AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.5.6 Peru AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.5.7 Puerto Rico AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.5.8 Ecuador AI-Enabled Imaging Modalities Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.6.2 Kuwait AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.6.3 Oman AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.6.4 Qatar AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.6.5 Saudi Arabia AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.6.6 United Arab Emirates AI-Enabled Imaging Modalities Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.7.2 South Africa AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.7.3 Egypt AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.7.4 Algeria AI-Enabled Imaging Modalities Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia AI-Enabled Imaging Modalities Consumption (2017-2022)

      • 10.8.2 New Zealand AI-Enabled Imaging Modalities Consumption (2017-2022)

    11 Global AI-Enabled Imaging Modalities Competitive Analysis

    • 11.1 Koninklijke Philips NV

      • 11.1.1 Koninklijke Philips NV Company Details

      • 11.1.2 Koninklijke Philips NV AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Koninklijke Philips NV AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.1.4 Koninklijke Philips NV AI-Enabled Imaging Modalities Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 General Electric Company

      • 11.2.1 General Electric Company Company Details

      • 11.2.2 General Electric Company AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 General Electric Company AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.2.4 General Electric Company AI-Enabled Imaging Modalities Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Fujifilm

      • 11.3.1 Fujifilm Company Details

      • 11.3.2 Fujifilm AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Fujifilm AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.3.4 Fujifilm AI-Enabled Imaging Modalities Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 United Health Imaging

      • 11.4.1 United Health Imaging Company Details

      • 11.4.2 United Health Imaging AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 United Health Imaging AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.4.4 United Health Imaging AI-Enabled Imaging Modalities Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Siemens Healthineers AG

      • 11.5.1 Siemens Healthineers AG Company Details

      • 11.5.2 Siemens Healthineers AG AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Siemens Healthineers AG AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.5.4 Siemens Healthineers AG AI-Enabled Imaging Modalities Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Konica Minolta Inc

      • 11.6.1 Konica Minolta Inc Company Details

      • 11.6.2 Konica Minolta Inc AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Konica Minolta Inc AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.6.4 Konica Minolta Inc AI-Enabled Imaging Modalities Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Nanox

      • 11.7.1 Nanox Company Details

      • 11.7.2 Nanox AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Nanox AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.7.4 Nanox AI-Enabled Imaging Modalities Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Butterfly Network Inc

      • 11.8.1 Butterfly Network Inc Company Details

      • 11.8.2 Butterfly Network Inc AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Butterfly Network Inc AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.8.4 Butterfly Network Inc AI-Enabled Imaging Modalities Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Agfa

      • 11.9.1 Agfa Company Details

      • 11.9.2 Agfa AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Agfa AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.9.4 Agfa AI-Enabled Imaging Modalities Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Hologic

      • 11.10.1 Hologic Company Details

      • 11.10.2 Hologic AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Hologic AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.10.4 Hologic AI-Enabled Imaging Modalities Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Canon Inc

      • 11.11.1 Canon Inc Company Details

      • 11.11.2 Canon Inc AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Canon Inc AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.11.4 Canon Inc AI-Enabled Imaging Modalities Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Exo

      • 11.12.1 Exo Company Details

      • 11.12.2 Exo AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Exo AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.12.4 Exo AI-Enabled Imaging Modalities Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Hyperfine

      • 11.13.1 Hyperfine Company Details

      • 11.13.2 Hyperfine AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Hyperfine AI-Enabled Imaging Modalities Main Business and Markets Served

      • 11.13.4 Hyperfine AI-Enabled Imaging Modalities Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global AI-Enabled Imaging Modalities Market Outlook by Types and Applications to 2028

    • 12.1 Global AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Computed Tomography (CT) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global MRI Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global X-Ray Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Ultrasound Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Positron Emission Tomography (PET) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Other Modalities Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Neurology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Pulmonology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise AI-Enabled Imaging Modalities Market Analysis and Outlook to 2028

    • 13.1 Global AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.2.2 Canada AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.2.3 Mexico AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.2 UK AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.3 Spain AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.4 Belgium AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.5 France AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.6 Italy AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.7 Denmark AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.8 Finland AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.9 Norway AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.10 Sweden AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.11 Poland AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.12 Russia AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.3.13 Turkey AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.2 Japan AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.3 India AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.4 South Korea AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.8 Thailand AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.9 Singapore AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.11 Philippines AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.5.2 Colombia AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.5.3 Chile AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.5.4 Argentina AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.5.6 Peru AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.6.3 Oman AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.6.4 Qatar AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.7.2 South Africa AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.7.3 Egypt AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.7.4 Algeria AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand AI-Enabled Imaging Modalities Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of AI-Enabled Imaging Modalities

    • Figure of AI-Enabled Imaging Modalities Picture

    • Table Global AI-Enabled Imaging Modalities Import by Region (Top 10 Countries) (2017-2028)

    • Table Global AI-Enabled Imaging Modalities Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Computed Tomography (CT) Consumption and Growth Rate (2017-2022)

    • Figure Global MRI Consumption and Growth Rate (2017-2022)

    • Figure Global X-Ray Consumption and Growth Rate (2017-2022)

    • Figure Global Ultrasound Consumption and Growth Rate (2017-2022)

    • Figure Global Positron Emission Tomography (PET) Consumption and Growth Rate (2017-2022)

    • Figure Global Other Modalities Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Neurology Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Table North America AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Figure United States AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Canada AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Mexico AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Table Europe AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Figure Germany AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure UK AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Spain AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Belgium AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure France AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Italy AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Denmark AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Finland AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Norway AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Sweden AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Poland AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Russia AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Turkey AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Table APAC AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Figure China AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Japan AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure India AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure South Korea AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Pakistan AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Indonesia AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Thailand AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Singapore AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Malaysia AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Philippines AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Vietnam AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Table South America AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Figure Brazil AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Colombia AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Chile AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Argentina AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Venezuela AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Peru AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Ecuador AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Table GCC AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Figure Bahrain AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Kuwait AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Oman AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Qatar AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Table Africa AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Figure Nigeria AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure South Africa AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Egypt AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure Algeria AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Table Oceania AI-Enabled Imaging Modalities Consumption by Country (2017-2022)

    • Figure Australia AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Figure New Zealand AI-Enabled Imaging Modalities Consumption and Growth Rate (2017-2022)

    • Table Koninklijke Philips NV Company Details

    • Table Koninklijke Philips NV AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Koninklijke Philips NV AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Koninklijke Philips NV AI-Enabled Imaging Modalities Product Portfolio

    • Table General Electric Company Company Details

    • Table General Electric Company AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table General Electric Company AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table General Electric Company AI-Enabled Imaging Modalities Product Portfolio

    • Table Fujifilm Company Details

    • Table Fujifilm AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fujifilm AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Fujifilm AI-Enabled Imaging Modalities Product Portfolio

    • Table United Health Imaging Company Details

    • Table United Health Imaging AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table United Health Imaging AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table United Health Imaging AI-Enabled Imaging Modalities Product Portfolio

    • Table Siemens Healthineers AG Company Details

    • Table Siemens Healthineers AG AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthineers AG AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Siemens Healthineers AG AI-Enabled Imaging Modalities Product Portfolio

    • Table Konica Minolta Inc Company Details

    • Table Konica Minolta Inc AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Konica Minolta Inc AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Konica Minolta Inc AI-Enabled Imaging Modalities Product Portfolio

    • Table Nanox Company Details

    • Table Nanox AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanox AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Nanox AI-Enabled Imaging Modalities Product Portfolio

    • Table Butterfly Network Inc Company Details

    • Table Butterfly Network Inc AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Butterfly Network Inc AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Butterfly Network Inc AI-Enabled Imaging Modalities Product Portfolio

    • Table Agfa Company Details

    • Table Agfa AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agfa AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Agfa AI-Enabled Imaging Modalities Product Portfolio

    • Table Hologic Company Details

    • Table Hologic AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Hologic AI-Enabled Imaging Modalities Product Portfolio

    • Table Canon Inc Company Details

    • Table Canon Inc AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Canon Inc AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Canon Inc AI-Enabled Imaging Modalities Product Portfolio

    • Table Exo Company Details

    • Table Exo AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exo AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Exo AI-Enabled Imaging Modalities Product Portfolio

    • Table Hyperfine Company Details

    • Table Hyperfine AI-Enabled Imaging Modalities Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hyperfine AI-Enabled Imaging Modalities Main Business and Markets Served

    • Table Hyperfine AI-Enabled Imaging Modalities Product Portfolio

    • Figure Global Computed Tomography (CT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MRI Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global X-Ray Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ultrasound Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Positron Emission Tomography (PET) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Table North America AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Figure United States AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Figure Germany AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure France AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Figure China AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure India AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Table South America AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Figure Brazil AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Figure Bahrain AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Figure Nigeria AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania AI-Enabled Imaging Modalities Consumption Forecast by Country (2022-2028)

    • Figure Australia AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand AI-Enabled Imaging Modalities Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.